Cell replacement plays an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD). In the Journal of Parkinson’s Disease, experts describe how newly developed stem cell technologies could be used to treat PD and discuss the challenges, as well as the great promise, of stem cell treatment.

According to the Global Burden of Disease study, neurological disorders such as, Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, are the leading cause of disability globally, and the fastest growing neurological disorder is Parkinson’s disease. The study found since 1990, the prevalence rate of Parkinson’s disease has increased 118% to

Boxing gyms around the world are helping patients diagnosed with Parkinson’s disease fight back. Parkinson’s disease is the second most common type of neurodegenerative disease affecting an estimated 7-10 million people worldwide. The disease is characterized by a progressive loss of muscle control leading to slow movement, rigidity, resting tremor

Parkinson’s disease is a progressive neurodegenerative disease that affects dopamine-producing neurons in the brain. The disease is characterized by a progressive loss of muscle control leading to bradykinesia (slow movement), rigidity, resting tremor, and postural instability.  As symptoms worsen, it may be difficult to walk, talk, and perform simple tasks.

Parkinson’s disease is a degenerative disorder of the central nervous system characterized by a progressive loss of muscle control leading to slow movements (bradykinesia), rigidity, resting tremor and postural instability. As symptoms worsen it may be difficult to walk, talk, and perform simple daily tasks. Non-motor symptoms can include; anxiety,

The results of a study evaluating more than 300,000 U.S. military veterans showed even a mild a concussion resulting in a loss of consciousness increases the risk of Parkinson’s disease.  Mild traumatic brain injuries (TBIs), commonly referred to as concussions, led to a 56% increased risk of developing Parkinson’s disease.

CNN reports at least 700 patients have died after using Parkinson’s drug to treat disease related psychosis On April 9, CNN reported hundreds of patients have died while taking the drug Nuplazid, a drug meant to control Parkinson’s disease psychosis. According to the CNN story, hundreds of patients have died

Parkinson’s disease is a neurodegenerative disease characterized by a progressive loss of muscle control leading to bradykinesia (slow movement), rigidity, resting tremor and postural instability.  As symptoms worsen, it may be difficult to walk, talk, and perform simple tasks. Non-motor symptoms can include; anxiety, depression, psychosis, and dementia. Note: Despite

Lewy bodies are abnormal accumulations of protein inside the nerve cells in the brainstem, or in the cortex, of patients with Parkinson’s disease.  Alpha-synuclein protein is one of the critical proteins, that accumulate and become toxic to neurons, playing a central role in the development of Parkinson’s Disease. In the